BIOA
BIOAGE LABS (BIOA)
NASDAQ
$16.06-$0.48 (-2.90%)
Price as of Jun 03, 2026 6:48 PM EDT
  • $768.6M
    Market Cap
  • 314.54%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
9.0M
N/A
N/A
N/A
Cost of Revenue
49.4M
+33.17%
37.1M
N/A
Gross Profit
-40.5M
+8.95%
-37.1M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-74.0M
+25.29%
-59.0M
N/A
Depreciation and Amortization Expense
200,000
0.00%
200,000
N/A
Total Operating Expenses
101.8M
+30.16%
78.2M
N/A
Operating Profit
-92.8M
+18.65%
-78.2M
N/A
Interest Income
13.1M
+35.90%
9.6M
N/A
Interest Expense
-700,000
-58.82%
-1.7M
N/A
Interest Income and Expense and Net
12.4M
+56.21%
7.9M
N/A
Total Nonoperating Income and Expense
12.2M
+71.84%
7.1M
N/A
Income before Taxes
-92.8M
+18.65%
-78.2M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-80.6M
+13.35%
-71.1M
N/A
Net Income from Continuing Operations Applicable to Common
-80.6M
+13.35%
-71.1M
N/A
Basic EPS and Net Income
-2.24
-66.21%
-6.63
N/A
Diluted EPS and Net Income
-2.24
-66.21%
-6.63
N/A
Basic Weighted Average Shares
35.9M
+234.99%
10.7M
N/A
Diluted Weighted Average Shares
35.9M
+234.99%
10.7M
N/A
Balance Sheet
Cash and Cash Equivalents
188.9M
-46.69%
354.3M
N/A
Short-Term Investments
92.2M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
281.1M
-20.67%
354.3M
N/A
Total Current Assets
286.8M
-19.69%
357.1M
N/A
Accumulated Depreciation
482,000
+29.92%
371,000
N/A
Property and Plant and Equipment and Net
963,000
+62.94%
591,000
N/A
Total Long-Term Assets
216,000
-10.00%
240,000
N/A
Total Assets
294.9M
-17.68%
358.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.6M
-55.87%
6.0M
N/A
Total Current Liabilities
20.1M
-27.50%
27.8M
N/A
Total Long-Term Debt
0
-100.00%
2.5M
N/A
Total Long-Term Liabilities
2.7M
-63.18%
7.3M
N/A
Total Liabilities
22.8M
-34.95%
35.1M
N/A
Retained Earnings
-333.4M
+31.88%
-252.8M
N/A
Total Stockholders Equity
272.1M
-15.81%
323.1M
N/A
Total Shares Outstanding
37.4M
+4.29%
35.9M
N/A
Cash Flow
Cash from Operating Activities
-81.6M
+58.43%
-51.5M
N/A
Capital Expenditures
719,000
+96.45%
366,000
N/A
Cash from Investing Activities
-95.2M
+25,915.30%
-366,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
11.5M
-96.99%
381.2M
N/A
Financials Ratio
Gross Margin
-449.74%
N/A
N/A
N/A
Operating Margin
-1,031.46%
N/A
N/A
N/A
Return on Assets
-24.68%
N/A
N/A
N/A
Return on Equity
-27.09%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
14.24
N/A
N/A
N/A
Cash Ratio
9.38
N/A
N/A
N/A
Debt-to-Equity Ratio
0.010
N/A
N/A
N/A
Debt-to-Assets Ratio
0.009
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow